Another clinical study aims to clarify the therapeutic effect of pyroptosis induction through the NLRP1 inflammasome in patients diagnosed with acute myeloid leukemia (AML), a heterogenous hematological malignancy driven by uncontrolled expansion of myeloid progenitor cells in bone marrow and in circulation. Here, NLRP1 is linked to acute myeloid leukemia.